{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027973",
    "licUnit": "1",
    "validDate": "2030-12-03 00:00:00.000",
    "issueDate": "2020-12-03 00:00:00.000",
    "oriIssueDate": "2020-12-03",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202797305",
    "prodNameC": "瑞迪采膜衣錠400毫克",
    "prodNameE": "REDISTRA (Imatinib Mesylate Tablets 400mg)",
    "indicationsName": [
        "治療正值急性轉化期（BLAST CRISIS）、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病（CML）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷慢性骨髓性白血病（CML）的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（Ph+ALL）且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（Ph+ALL）之單一療法。治療患有與血小板衍生生長因子受體（PDGFR）基因重組相關之骨髓發育不全症候群（MDS）／骨髓增生性疾病（MPD）之成人患者。治療患有系統性肥大細胞增生症（SM），限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。治療嗜伊紅性白血球增加症候群（HES）與／或慢性嗜伊紅性白血病（CEL）且有血小板衍生生長因子受體（PDGFR）基因重組之成人患者。作為成人KIT（CD 117）陽性胃腸道基質瘤完全切除（complete gross resection）後之術後輔助治療。治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（PDGFR）基因重組之隆突性皮膚纖維肉瘤（DFSP）之成人患者。"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "2-1000錠",
            "packageUnit": "KS"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": "B",
    "mainCategory": "B",
    "drBaseId": "E8D3E148-D800-4E67-A0F0-1746A5121845",
    "subCategory": [
        "B02"
    ],
    "ingredientsDesc": [
        "IMATINIB MESYLATE"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "1Q 不得輸入",
        "24 監視期滿學名藥",
        "67 成品已完成元素不純物評估(Option 1、2a、2b)"
    ],
    "applicantName": "台灣瑞迪博士有限公司",
    "applicantAddr": "臺北市信義區信義路5段7號57樓之1(5727室)",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "8FB1C00D-9C28-4578-9079-1C222D62CBA7",
            "factoryCode": "1",
            "factoryName": "DR. REDDY’S LABORATORIES LTD.",
            "factoryAddr": "FORMULATION UNIT-VII, PLOT NO. P1 TO P9, PHASE-III, VSEZ, DUVVADA, VISAKHAPATNAM DISTRICT 530046, ANDHRA PRADESH, INDIA",
            "factoryCompanyAddr": null,
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN1049100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000710",
            "ingredientsName": "IMATINIB MESYLATE",
            "ingredientsDesc": "IMATINIB MESYLATE",
            "concentDesc": "(eq. to Imatinib.....400mg)",
            "concent": "477.880000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EA01"
        }
    ],
    "udiInfoList": [],
    "licBaseId": "F2099508-CA5E-47F7-AD56-BCE8E62EFFB4"
}